| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Top7 or 10 Tips > Top 6.9 Reasons Not to Give Away Your Top 7 Secret Business Tips |
|
Useful Advices - Top 6.9 Reasons Not to Give Away Your Top 7 Secret Business Tips
Many business consultants promote themselves thru information selling techniques such as displaying websi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product te information or writing articles in Trade Publication or Online. One common practice is to tell of Secr ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in et Industry Tips to entice potential clientele into signing up for consulting services. But often some o lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. f these poor consultants have so little information to give that once they blow their wad or spill the be here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ns, well they ain’t got nothing left to tell. This is problematic because the consultee is expectin d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro g expert advice and know how based on many years of observation, experience and real world doing it. Here ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc are the top 6.9 reasons a consultant should not give out all his or her knowledge in Top 7 articles on t easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi eir website or in trade journals. 1.) If you write a monthly column in a Trade Journal then eventually nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically you will have given away all your expertise. 2.) The more information you give away, sometimes the less and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ your potential clients need. 3.) If you give all your information away, then it is considered of zero ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi conomic value so why pay for it. 4.) If you give all the industry information away you increase competi ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a tion and decrease the need for consultants. 5.) If you put all your knowledge on your website then your dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod potential clients will take it and never hirer you. 6.) If you post all your information in 35 articles cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin on Top 7 Tips, secrets or reasons on an online article submission site then they will be syndicated to t tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen e world and then no one will need consultants in your industry again. 6.9) I am will not tell you all my t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel secrets because if you want more knowledge you will have to hire me as your consultant you see? Persona ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust lly, I am not a consultant type although have consulted some in my day. I find it appalling the amount of y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products work that many professional parasites do in order to hide industry information in the form of secrets. Ye . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de t as I contemplate their reasoning, I see their logic. This article is written from their perspective and elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip the battle which goes on inside their head in considering all this and the abundance of information flow tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Outsourcing, Virtual Teams and Cybermediaries - Part 1 Online Data Backup: Better Protection for Small Business
|